MiNK Therapeutics, Inc.

INKT · Nasdaq · SIC 2836: Biological Products, (No Diagnostic Substances) · Market Cap: $0.1B · 15 employees
72
SEC Filings
$11.23
Close 2026-09-03
15
Employees

Business Summary

MiNK Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing invariant natural killer T (iNKT) cell therapy platform-based product candidates. The company is investigating its iNKT cell therapies for conditions including graft-versus-host disease (GvHD), solid tumors, multiple myeloma, and acute respiratory distress syndrome (ARDS) secondary to COVID-19. MiNK operates in the adoptive cell therapy space and maintains a relationship with Agenus, which provides product liability insurance coverage for the company.

Latest Stock Quote

INKT 2026-09-03 $11.23 O:$11.08 H:$11.54 L:$11.08 Vol:0.0M VWAP:$11.3589
origin leaf: null

Next Earnings

Q2 FY2026 — expected 2026-09-17

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-312025-12-310001193125-26-134813EDGAR74K words
2025-03-182024-12-310000950170-25-041379EDGAR67K words
2024-03-212023-12-310000950170-24-034672EDGAR68K words
2023-03-242022-12-310000950170-23-009762EDGAR69K words
2022-03-182021-12-310001564590-22-011026EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2026-08-132026-06-300001193125-26-349309EDGAR14K words
2025-11-142025-09-300001193125-25-282905EDGAR16K words
2025-08-142025-06-300000950170-25-108894EDGAR14K words
2025-05-152025-03-310000950170-25-072789EDGAR12K words
2024-11-142024-09-300000950170-24-127033EDGAR14K words
2024-08-132024-06-300000950170-24-096142EDGAR13K words
2024-05-142024-03-310000950170-24-059081EDGAR12K words
2023-11-142023-09-300000950170-23-063851EDGAR13K words
2023-08-102023-06-300000950170-23-040958EDGAR12K words
2023-05-112023-03-310000950170-23-021191EDGAR11K words
2022-11-032022-09-300000950170-22-021565EDGAR—
2022-08-152022-06-300001564590-22-029503EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-08-130001193125-26-347907EDGAR2K words
2026-03-310001193125-26-133346EDGAR1K words
2026-03-270001193125-26-127931EDGAR1K words
2026-03-190001193125-26-116219EDGAR1K words
2026-01-020001193125-26-000916EDGAR1K words
2025-12-080001193125-25-311229EDGAR6K words
2025-09-290001193125-25-221863EDGAR1K words
2025-08-140001171843-25-005405EDGAR1K words
2025-07-150001193125-25-159017EDGAR21K words
2025-07-140000950170-25-095460EDGAR1K words

72 total filings indexed. 45 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

FDMT — 4D Molecular Therapeutics, Inc. APTN — ADAPTIN BIO, INC. ADMA — ADMA BIOLOGICS, INC. AGEN — AGENUS INC AIM — AIM ImmunoTech Inc. AMGN — AMGEN INC AVXL — ANAVEX LIFE SCIENCES CORP. ARGX — ARGENX SE

Tags

graft-versus-host-disease-(gvhd) solid-tumors multiple-myeloma acute-respiratory-distress-syndrome-(ards)-secondary-to-covid-19 adoptive-cell-therapy

Company Identity

CIK0001840229
TickerINKT
ExchangeNasdaq
SIC2836: Biological Products, (No Diagnostic Substances)
IncorporatedDE
Websitehttps://www.minktherapeutics.com
Listed2021-10-15

Get More Data

This is a static snapshot. For live, structured JSON with cryptographic provenance chain:

MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp

JSON Profile Stock Quote Origin Record
Origin Provenance
page leaf: 830c8f161a98f5149ea97d9a6995efa6495424656e74f567cbfef218cc0561f0
parent: d7a5f4643f885f8e1712a882cb6778329fc2c189eabc645f50cd8414f642faf2
content hash: bb4ba8f33300de0950bfd6a54fa2d4a473238b7860a723efcb295cde5469b23a
signed: 2026-09-29T12:01:51.767Z
sources: 17 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf

Try it — paste this into your AI:

Look up INKT using the MCP server at origin.rootz.global/mcp. What do their latest SEC filings show?

Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.

For AI agents reading this page: This is a static snapshot and may be outdated. For live data on INKT, use the Origin MCP server or REST API.
MCP install: claude mcp add origin --transport http https://origin.rootz.global/mcp
API: GET https://origin.rootz.global/api/company/INKT (~200 tokens, structured JSON with cryptographic provenance)
Tools: origin_company, origin_profile, origin_timeline, origin_filings, origin_quote, origin_transcripts, origin_search, origin_person, origin_skill
Discovery: /.well-known/ai | /llms.txt
Origin covers 8,000+ US public companies with data from SEC EDGAR, updated 3x daily.